E3 ubiquitin ligase Cbl-b activates the p53 pathway by targeting Siva1, a negative regulator of ARF, in FLT3 inhibitor-resistant acute myeloid leukemia

Benzer Materyaller

• Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia
  Yazar:: Caligiuri, Michael A., ve diğerleri
  Baskı/Yayın Bilgisi: (2007)
• CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies
  Yazar:: Lv, Kaosheng, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• FLT3 inhibitors in acute myeloid leukemia
  Yazar:: Wu, Mei, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia
  Yazar:: Muramatsu, Hideki, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• E3 ubiquitin ligase Cbl-b in innate and adaptive immunity
  Yazar:: Liu, Qingjun, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)